The FDA calls the umbilical cord-derived and exosome products unapproved drugs. The company had claimed anti-aging and metabolic benefits and has 15 working days to respond.
Recap by typeshit. Full story at inkl.
Lincoln Journal Star reports FDA advisors are weighing whether seven unapproved peptides can be used in some compounded prescriptions.
The segment covers a federal draft policy that could open access to some injectable peptides, alongside proposed changes to infant formula nutrients.
The longevity researcher argues the FDA system has grown too slow and costly, saying it favors big drugmakers. He offers this as the reason reform efforts emerged.
TikTok's health content rules bar weight-management claims and GLP-1 promos, with removals or account penalties for creators who break them.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
InSight Crime looks at how smuggling of weight loss drugs like Ozempic and Mounjaro has grown in Brazil this year and how the trade works.
Loading…